Know Cancer

or
forgot password

    • cancer clinical trials in clearwater, FL

    • Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    Morton Plant Hospital
    Clearwater, Florida 33756
    Breast Cancer
    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Lung Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Morton Plant Hospital
    Clearwater, Florida 33756
    Breast Cancer
    Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Head and Neck Cancer, Oral Complications
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
    Donald Bergner, MD
    Clearwater, Florida 33761
    Prostatic Hyperplasia
    Study of REN-1654 in Patients With Sciatica Pain
    Clinical Research of West Florida
    Clearwater, Florida 33765
    Sciatica, Herniated Disc, Radiculopathy
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Morton Plant Hospital
    Clearwater, Florida 33756
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Morton Plant Hospital
    Clearwater, Florida 33756
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
    Morton Plant Hospital
    Clearwater, Florida 33756
    HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
    Pfizer Investigational Site
    Clearwater, Florida 33761
    Chronic Myeloid Leukemia
    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
    Research Alliance, Inc.
    Clearwater, Florida 33756
    Venous Thrombosis
    Prospective Observational Epidemiologic Study of Maraviroc's Safety
    Pfizer Investigational Site
    Clearwater, Florida 33761
    Human Immunodeficiency Virus
    Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
    Pfizer Investigational Site
    Clearwater, Florida 33761
    Kidney Neoplasms
    Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
    Pfizer Investigational Site
    Clearwater, Florida 33761
    Advanced Breast Cancer, Breast Cancer
    PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
    Pfizer Investigational Site
    Clearwater, Florida 33761
    Carcinoma, Non-small Cell
    Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer
    Pfizer Investigational Site
    Clearwater, Florida 33761
    Carcinoma, Renal Cell
    Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer
    Pfizer Investigational Site
    Clearwater, Florida 33761
    Breast Cancer, Advanced Breast Cancer
    Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
    Pfizer Investigational Site
    Clearwater, Florida 33761
    Kidney Neoplasms
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Morton Plant Hospital
    Clearwater, Florida 33756
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer
    Pfizer Investigational Site
    Clearwater, Florida 33761
    Non-Small Cell Lung Cancer
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Morton Plant Hospital
    Clearwater, Florida 33756
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Morton Plant Hospital
    Clearwater, Florida 33756
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    ARCHER 1009 : A Study Of PF-00299804 (Dacomitinib) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Clearwater, Florida 33761
    Non-Small Cell Lung Cancer (NSCLC)
    Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
    Morton Plant Mease Health Care
    Clearwater, Florida 33756
    Oral Mucositis
    A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
    Pfizer Investigational Site
    Clearwater, Florida 33761
    Endometrial Neoplasms
    MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I
    Morton Plant Mease Health Care
    Clearwater, Florida 33756
    Breast Cancer
    A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
    Pfizer Investigational Site
    Clearwater, Florida 33761
    Acute Myeloid Leukemia
    Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Lung Cancer
    Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Prostate Cancer
    Talc in Treating Patients With Malignant Pleural Effusion
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Metastatic Cancer
    Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Metastatic Cancer
    Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Sarcoma
    Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Breast Cancer
    Brachytherapy in Treating Patients With Prostate Cancer
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Prostate Cancer
    Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Pancreatic Cancer
    Eflornithine in Treating Patients With Bladder Cancer
    Tampa Bay Meical Research
    Clearwater, Florida 33761
    Bladder Cancer
    Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Diarrhea, Radiation Enteritis
    Positron Emission Tomography for Detecting Non-Small Cell Lung Cancer
    Morton Plant Mease Health Care
    Clearwater, Florida 33756
    Lung Cancer
    Positron Emission Tomography in Determining Stage of Esophageal Cancer
    Morton Plant Hospital
    Clearwater, Florida 33756
    Esophageal Cancer
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Head and Neck Cancer
    External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Prostate Cancer
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Brain and Central Nervous System Tumors
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    Lykes Center for Radiation Therapy
    Clearwater, Florida 33757-0210
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Clinical Trial in Males With BPH (Enlarged Prostate)
    Tampa Bay Medical Research, Inc.
    Clearwater, Florida 34621
    Urinary Retention, Prostatic Hyperplasia, Benign Prostatic Hypertrophy
    For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy
    Pfizer Investigational Site
    Clearwater, Florida 33761
    Neoplasm Metastasis, Colorectal Neoplasms
    Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer
    Pfizer Investigational Site
    Clearwater, Florida 33761
    Breast Neoplasms
    Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
    Pfizer Investigational Site
    Clearwater, Florida 33761
    Non-Hodgkin Lymphoma, Hodgkin Disease, Thrombocytopenia
    PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)
    Pfizer Investigational Site
    Clearwater, Florida 33761
    Melanoma, Breast Neoplasms, Carcinoma, Renal Cell, Lymphoma, T-Cell, Carcinoma, Non-Small-Cell Lung
    CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer
    Pfizer Investigational Site
    Clearwater, Florida 33761
    Carcinoma, Breast